Immune-Privileged Site Targeting
Definition
Choosing disease targets located in body regions with limited immune access, such as the retina, so that viral-vector therapies provoke less immune response.
Cast within
No topic-region cast yet — this appears once Immune-Privileged Site Targeting's compiled claims are aligned into a topic region's argument tree.
Claims mentioning Immune-Privileged Site Targeting (1)
Your notes
Loading notes...